항생제 내성: 지난 50년간의 변화와 향후 전망 - 그람양성균
Antimicrobial Resistance in Gram-positive Cocci: Past 50 Years, Present and Future
1
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Widespread development of antimicrobial resistance by major bacterial pathogens including Staphylococcus aureus, Streptococcus pneumoniae, Enterococci, and gram-negative bacilli have emerged as a global healthcare concern. Antimicrobial resistance was first identified during the 1940s and 50s with penicillin resistance in S. aureus . During the 1970s and 80s, methicillin-resistant S. aureus (MRSA) rapidly emerged as a major nosocomial pathogen in hospitals throughout the world. In the 1990s, a variation of MRSA emerged as community-associated MRSA (CA-MRSA), which is contracted outside of the hospital setting, and has become one of the most common pathogens associated with skin and skin structure infections in the United States and other parts of the world. Vancomycin-intermediate S. aureus (VISA) was first reported in 1996, and high-level vancomycin-resistant S. aureus (VRSA) was reported in 2002. S. pneumoniae has demonstrated a significant increase in resistance to macrolides and beta-lactam agents since 1980s, particularly in Asian countries while penicillin resistance is not prevalent among non-meningeal isolates according to the new breakpoints from CLSI. Vancomycin resistant enterococci, particularly E. faecium, is a major concern associated with nosocomial infections in many hospitals. Given the widespread emergence and spread of antimicrobial resistant gram-positive cocci during recent decades, the problem is likely to continue to increase as a critical, clinical problem.
Abstract
Widespread development of antimicrobial resistance by major bacterial pathogens including Staphylococcus aureus, Streptococcus pneumoniae, Enterococci, and gram-negative bacilli have emerged as a global healthcare concern. Antimicrobial resistance was first identified during the 1940s and 50s with penicillin resistance in S. aureus . During the 1970s and 80s, methicillin-resistant S. aureus (MRSA) rapidly emerged as a major nosocomial pathogen in hospitals throughout the world. In the 1990s, a variation of MRSA emerged as community-associated MRSA (CA-MRSA), which is contracted outside of the hospital setting, and has become one of the most common pathogens associated with skin and skin structure infections in the United States and other parts of the world. Vancomycin-intermediate S. aureus (VISA) was first reported in 1996, and high-level vancomycin-resistant S. aureus (VRSA) was reported in 2002. S. pneumoniae has demonstrated a significant increase in resistance to macrolides and beta-lactam agents since 1980s, particularly in Asian countries while penicillin resistance is not prevalent among non-meningeal isolates according to the new breakpoints from CLSI. Vancomycin resistant enterococci, particularly E. faecium, is a major concern associated with nosocomial infections in many hospitals. Given the widespread emergence and spread of antimicrobial resistant gram-positive cocci during recent decades, the problem is likely to continue to increase as a critical, clinical problem.
참고문헌 (49)
- Boucher HW, "Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America", Clin Infect Dis, 48, pp.1~12 (2009)
- Hiramatsu K, "Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility", J Antimicrob Chemother, 40, pp.135~136 (1997)
- Centers for Disease Control and Prevention (CDC), "Staphylococcus aureus resistant to vancomycin--United States, 2002", MMWR Morb Mortal Wkly Rep, 51, pp.565~567 (2002)
- Grundmann H, "Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat", Lancet, 368, pp.874~885 (2006)
- Deurenberg RH, "The evolution of Staphylococcus aureus", Infect Genet Evol, 8, pp.747~763 (2008)
- Ko KS, "Distribution of major genotypes among methicillin-resistant Staphylococcus aureus clones in Asian countries", J Clin Microbiol, 43, pp.421~426 (2005)
- 오향순, "Multicenter surveillance study for nosocomial infections in major hospitals in Korea", American Journal of Infection Control, 28(6), pp.454~458 (2000), Mosby Inc.
- Chong Y, "Korean nationwide surveillance of antimicrobial resistance of bacteria in 1997", Yonsei Med J, 39, pp.569~577 (1998)
- Lee K, "Korean nationwide surveillance of antimicrobial resistance of bacteria in 1998", Yonsei Med J, 41, pp.497~506 (2000)
- Kim HB, "In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey", Antimicrob Agents Chemother, 48, pp.1124~1127 (2004)
- Hong SG, "Antimicrobial resistance of clinically important bacteria isolated from hospitals located in representative provinces of Korea", Korean J Clin Microbiol, 6, pp.29~36 (2003)
- Hong SG, "Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea", Korean J Clin Microbiol, 7, pp.171~177 (2004)
- 이혁민, "2004년도 국내 12개 병원에서 분리된 주요 세균의 항균제 내성율", 대한임상미생물학회지, 8(1), pp.66~73 (2005), 대한임상미생물학회
- 이혁민, "2005∼2006년 국내 12개 병원에서 분리된 주요 세균의 항균제 내성률", 대한임상미생물학회지, 10(1), pp.59~69 (2007), 대한임상미생물학회
- Salgado CD, "Community-acquired methicillin- resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors", Clin Infect Dis, 36, pp.131~139 (2003)
- Moran GJ, "Methicillin-resistant S. aureus infections among patients in the emergency department", N Engl J Med, 355, pp.666~674 (2006)
- Liu C, "A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005", Clin Infect Dis, 46, pp.1637~1646 (2008)
- Naimi TS, "Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection", JAMA, 290, pp.2976~2984 (2003)
- Song JH, "Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study", J Antimicrob Chemother, 66, pp.1061~1069 (2011)
- Kim HB, "The methicillin-resistance rate of Staphylococcus aureus isolatd from anterior nares of healthy adults in the community", Korean J Infect Dis, 30, pp.527~531 (1998)
- Kim ES, "A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 60, pp.1108~1114 (2007), OXFORD UNIV PRESS
- Mun HM, "Community and hospital onset methicillin-resistant Staphylococcus aureus in a tertiary care teaching hospital", Korean J Nosocomial Infect Control, 14, pp.24~35 (2009)
- 정경태, "Nationwide Surveillance Study of Vancomycin-Intermediate Staphylococcus aureus Strains in Korean Hospitals from 2001 to 2006", Journal of Microbiology and Biotechnology, 20(3), pp.637~642 (2010), 한국미생물·생명공학회
- Howden BP, "Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin- intermediate strains: resistance mechanisms, laboratory detection, and clinical implications", Clin Microbiol Rev, 23, pp.99~139 (2010)
- Périchon B, "VanA-type vancomycin-resistant Staphylococcus aureus", Antimicrob Agents Chemother, 53, pp.4580~4587 (2009)
- Tiwari HK, "Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India", BMC Infect Dis, 6, pp.156~ (2006)
- Aligholi M, "Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran", Med Princ Pract, 17, pp.432~434 (2008)
- Chambers HF, "The changing epidemiology of Staphylococcus aureus", Emerg Infect Dis, 7, pp.178~182 (2001)
- Hansman D, "Penicillin-insensitive pneumococci", Br Med J, 2, pp.1503~1504 (1976)
- Jacobs MR, "Emergence of multiply resistant pneumococci", N Engl J Med, 299, pp.735~740 (1978)
- Kim SH, "Changing trend of antimicrobial resistance and serotypes in Streptococcus pneumoniae in Asian countries: an ANSORP study", Antimicrob Agents Chemother
- Hsueh PR, "Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan", Clin Microbiol Infect, 12, pp.296~298 (2006)
- Uttley AH, "Vancomycinresistant Enterococci", Lancet, 1, pp.57~58 (1988)
- Leclercq R, "Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium", N Engl J Med, 319, pp.157~161 (1988)
- Frieden TR, "Emergence of vancomycinresistant Enterococci in New York City", Lancet, 342, pp.76~79 (1993)
- Reik R, "The burden of vancomycin- resistant enterococcal infections in US hospitals, 2003 to 2004", Diagn Microbiol Infect Dis, 62, pp.81~85 (2008)
- Deshpande LM, "Antimicrobial resistance and molecular epidemiology of vancomycin-resistant Enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program", Diagn Microbiol Infect Dis, 58, pp.163~170 (2007)
- Werner G, "Emergence and spread of vancomycin resistance among Enterococci in Europe", Euro Surveill, 13, pp.pii 19046~ (2008)
- Brown DF, "Non-susceptibility trends among Enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06", J Antimicrob Chemother, 62(2), pp.ii75~ii85 (2008)
- Bonten MJ, "Vancomycin-resistant Enterococci: why are they here, and where do they come from", Lancet Infect Dis, 1, pp.314~325 (2001)
- Klare I, "Decreased incidence of VanA-type vancomycin-resistant Enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry", Microb Drug Resist, 5, pp.45~52 (1999)
- Salgado CD, "Outcomes associated with vancomycinresistant Enterococci: a meta-analysis", Infect Control Hosp Epidemiol, 24, pp.690~698 (2003)
- DiazGranados CA, "Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis", Clin Infect Dis, 41, pp.327~333 (2005)
- Park JW, "Susceptibility tests of vancomycin-resistant Enterococci", Korean J Infect Dis, 24, pp.133~137 (1992)
- Kyungwon Lee, "Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009", Yonsei Medical Journal, 52(5), pp.793~802 (2011), 연세대학교의과대학
- "Korea Nosocomial Infections Surveillance System (KONIS) Report : Data Summary from July 2009 through June 2010"[URL]
- Choi JH, "Colonization rate, risk factor for acquisition and genetic diversity of vancomycin-resistant Enterococci (VRE) isolated from rectal culture of patients in intensvie care units from ten large hospitals in Korea", Korean J Infect Dis, 34, pp.276~284 (2002)
- Yi SH, "Prevalence of vanA vancomycin-resistant Enterococci and epidemiologic survey of chicken farms located in Seoul and Kyunggi province", Korean J Nosocomial Infect Control, 12, pp.77~84 (2007)
- Han SH, "Vancomycin-resistant enterococci bacteremia: Risk factors for mortality and influence of antimicrobial therapy on clinical outcome", Journal Of Infection, 58(3), pp.182~190 (2009), W. B. Saunders Co., Ltd.